← Medication Database
Oncology

Loqtorzi

Generic: toripalimab-tpzi

Manufacturer: Coherus Biosciences  ·  Program: LOQTORZI Solutions Patient Assistance Program

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Uninsured or functionally underinsured (not government-funded programs)

Residency

US resident

Income Threshold

Up to 500% FPL

Adjusted annual household income ≤500% FPL for uninsured or functionally underinsured

Program Information

Processing Time

2–4 weeks

Delivery Method

shipped to patient or physician office

Application Method

Multiple

Reauthorization

Required, annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Income documentation or consent for credit check
  • Signed consent form

Indicated For

recurrent locally advanced or metastatic nasopharyngeal carcinoma

About This Medication

# LOQTORZI Solutions Patient Assistance Program Patient Guide: How to Get Loqtorzi (toripalimab-tpzi) at Low or No Cost Loqtorzi (toripalimab-tpzi) is an FDA-approved immunotherapy for adults with nasopharyngeal carcinoma (NPC), a type of head and neck cancer. The **LOQTORZI Solutions Patient Assistance Program** from **Coherus Biosciences** provides **Loqtorzi at no cost** to eligible uninsured or functionally underinsured patients facing financial hardship.[1][5] ## About Loqtorzi (toripalimab-tpzi) Loqtorzi is a prescription medicine used to treat adults with **nasopharyngeal carcinoma (NPC)**, which affects the nasopharynx (upper part of the throat behind the nose). It works as an immune checkpoint inhibitor, helping your immune system fight cancer cells.[3][8] **Approved uses:** - In combination with **cisplatin and gemcitabine** as **first-line treatment** for **metastatic or recurrent, locally advanced NPC**. - As a **single agent** for **recurrent unresectable or metastatic NPC** after disease progression on or after platinum-containing chemotherapy.[2][3][5] **How it's given:** Loqtorzi is administered as an **IV infusion** (through a vein) by a nurse at your doctor's office or infusion center. Treatment often starts with 6 cycles of Loqtorzi plus chemotherapy every 3 weeks, followed by Loqtorzi alone (chemo-free) for up to 24 months if effective.[8] **Important safety note:** Loqtorzi can cause serious side effects like immune-related problems (e.g., lung, liver, or thyroid issues), infusion reactions, or Guillain-Barré syndrome. Your doctor will monitor you closely and may adjust treatment.[8][9] Always discuss with your oncologist if Loqtorzi is right for you. ## Who Qualifies for the Program? This program is for **uninsured** or **functionally underinsured** patients (those with insurance that doesn't adequately cover Loqtorzi, but **not** government-funded like Medicare, Medicaid, VA, or TRICARE).[1][5][7] You must meet **all** criteria: - US resident, age 18+. - Under care of a US-licensed provider in an outpatient setting. - Diagnosis and dosing match FDA-approved indications (or provider deems medically necessary).[5] - **Adjusted annual household income ≤500% of the Federal Poverty Level (FPL)**.[5][10] - Provide income proof or consent to credit check; sign consent form.[5] **Note:** Program covers only the drug cost, not administration or office visits. Not valid where prohibited; Coherus may change/terminate anytime.[5] ## Income Eligibility Breakdown Eligibility is based on **household size** and **adjusted annual income** at or below **500% FPL**. Use the table below for 2026 guidelines (FPL updates annually; verify current at [healthcare.gov](https://www.healthcare.gov)). | Household Size | Max Annual Income (500% FPL) | |----------------|------------------------------| | 1 (Individual) | $73,950 | | 2 (Couple) | $100,000 | | 3 | $126,050 | | 4 | $152,100 | | +1 per member | +$26,050 | *Examples: A single person earning ≤$73,950 qualifies; a family of 4 ≤$152,100. Include all household income (taxable + some nontaxable). Deduct certain expenses for 'adjusted' income.*[5][10] ## Insurance Requirements - **Eligible:** Uninsured or **functionally underinsured** (high copays/deductibles make Loqtorzi unaffordable, but no government coverage).[1][5] - **Not eligible:** Medicare, Medicaid, Medicare Advantage, VA, TRICARE, or other government programs. Commercial insurance patients may use the separate Co-Pay Savings Program (up to $30,000/year, $0/dose possible).[4][5] If insurance changes to government-funded, report immediately to (844) 483-3692.[4] ## Step-by-Step Application Process 1. **Talk to your doctor:** Confirm Loqtorzi prescription and eligibility. Your oncologist starts the process.[2][5] 2. **Contact LOQTORZI Solutions:** Call **(844) 483-3692** Mon-Fri. Multiple methods: phone, HCP portal, or forms.[5][7] 3. **Submit documents:** - Proof of income (tax returns, pay stubs, W-2s) **or** consent for credit check. - Signed consent form. - Prescription, proof of no/poor insurance.[5] 4. **Doctor completes forms:** Includes diagnosis, dosing, and medical necessity.[5] 5. **Wait for approval:** If approved, Loqtorzi ships free.[1] Applications are reviewed quickly; **reauthorization** needed periodically.[5] ## Timeline and Delivery - **Processing:** Typically days to weeks (exact time varies; call for status).[1] - **Delivery:** Ships directly to **you or your doctor's office** at no cost.[5] - **Refills:** **Reauthorization required**; resubmit proof of ongoing need/response to therapy.[2][5] Track via phone support. ## Alternatives if Denied or Ineligible - **Co-Pay Savings Program:** For commercial insurance; up to $30,000/year assistance.[4][5][6] - **Other PAPs:** Check rxassist.org or needymeds.org.[10] - **State programs, foundations:** CancerCare, Patient Access Network (PAN). - **Discuss with oncologist:** Biosimilars (none currently); generics unlikely; trial enrollment.[2] - **Appeal denial:** Provide more docs or updated income.[5] **No biosimilar alternatives listed for Loqtorzi.**[program data] ## Disclaimer This guide is for informational purposes only and based on program details as of March 2026. Eligibility, terms, and availability can change. Coherus Biosciences reserves the right to modify/terminate without notice. Not a guarantee of coverage. Consult your healthcare provider and call (844) 483-3692 for personalized advice. Read full Prescribing Info and Medication Guide. Report side effects to FDA at 1-800-FDA-1088.[1][5][8]

Program information last verified: March 25, 2026

Ready to apply for Loqtorzi assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications